IP Library Granted Patent US 9,328,061
Granted Patent B2
US 9,328,061 · App. 14/382,053 · Granted May 3, 2016

Simple organic molecules as catalysts for practical and efficient enantioselective synthesis of amines and alcohols

Inventors: Amir H. Hoveyda (Lincoln, MA); Daniel L. Silverio (Chestnut Hill, MA); Tatiana Pilyugina (Waltham, MA); Sebastian Torker (Brighton, MA); Daniel Robbins (Boston, MA)
Assignee: Trustees of Boston College
C07C237/06C07C29/38C07C41/30C07C67/343C07C227/10C07C229/08C07C229/14C07C251/24C07D207/06C07D295/185C07F7/0812C07F7/0818C07F9/36C07F9/5022C07F9/6539C07B2200/07C07C229/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,328,061
App. No.
14/382,053
Granted
May 3, 2016
Kind
B2
Abstract

The present invention provides organic molecules and methods thereof for reactions between organoboron reagents and double bonds, such as imines or carbonyls, to stereoselectively provide chiral products including amines and alcohols, entities useful for the preparation of biologically active molecules.

Claims (38)

1. A compound selected from the group consisting of

2. A compound having the structure of formula I-a:

wherein:

X is —O—;

each of R 2 , R 3 , and R 6 is independently R, —OR, —N(R) 2 , —SR, or —C(O)L;

L is R, halogen, —OR, —N(R) 2 , or —SR;

each R is independently hydrogen or R′; and

each R′ is independently unsubstituted C 1-12 aliphatic or an optionally substituted group selected from the group consisting of phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 4-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, and an 8-10 membered bicyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or

two R′ groups on the same nitrogen atom are optionally taken together with the nitrogen atom to form an optionally substituted 3-8 membered, saturated, partially unsaturated, or aryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or

two R′ groups on the same carbon atom are optionally taken together with their intervening atoms to form an optionally substituted 3-8 membered saturated or partially unsaturated spirocycle ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or

two R′ groups on adjacent atoms are optionally taken together with their intervening atoms form an optionally substituted 3-8 membered, saturated, partially unsaturated, or aryl ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur,

wherein the R 1 at the o position of —XH is tert-butyl and each other R 1 is hydrogen.

3. A compound having the structure of formula I-a:

wherein:

each R′ is independently R, halogen, —OR, —N(R) 2 , —SR, —NO 2 , —SOR, —SO 2 R, —Si(R) 3 , or —C(O)L;

X is —O—;

independently ( . . . )—N(R) 2 ;

each R is independently hydrogen or R′; and

each R′ is independently unsubstituted C 1-12 aliphatic or an optionally substituted group selected from the group consisting of phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 4-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, and an 8-10 membered bicyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitro en ox en or sulfur; or

two R′ groups on the same nitrogen atom are optionally taken together with the nitro en atom to form an optionally substituted 3-8 membered, saturated, partially unsaturated, or aryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or

two R′ groups on the same carbon atom are optionally taken together with their intervening atoms to form an optionally substituted 3-8 membered saturated or partially unsaturated spirocycle ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or

two R′ groups on adjacent atoms are optionally taken together with their intervening atoms form an optionally substituted 3-8 membered, saturated, partially unsaturated, or aryl ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur,

wherein one R 3 is hydrogen and the other R 3 is isopropyl.

4. A compound having the structure of formula I-a:

wherein:

each R 1 is independently R, halogen, —OR, —N(R) 2 , —SR, —NO 2 , —SOR, —SO 2 R, —Si(R) 3 , or —C(O)L;

X is —O—;

independently ( . . . ) —SR, or —C(O)L;

L is R, halogen, —OR, —N(R) 2 , or —SR;

each R is independently hydrogen or R′; and

each R′ is independently unsubstituted C 1-12 aliphatic or an optionally substituted group selected from the group consisting of phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring having 8-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 4-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, and an 8-10 membered bicyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or

two R′ groups on the same nitrogen atom are optionally taken together with the nitrogen atom to form an optionally substituted 3-8 membered, saturated, partially unsaturated, or aryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or

two R′ groups on the same carbon atom are optionally taken together with their intervening atoms to form an optionally substituted 3-8 membered saturated or partially unsaturated spirocycle ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or

two R′ groups on adjacent atoms are optionally taken together with their intervening atoms form an optionally substituted 3-8 membered, saturated, partially unsaturated, or aryl ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur,

wherein;

each R 6 is independently R′, or:

one is hydrogen and the other is R′, wherein R′ is unsubstituted C 1-12 aliphatic, or an optionally substituted group selected from the group consisting of phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 4-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, and an 8-10 membered bicyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur.

5. The compound of claim 4 , wherein each R 6 is independently unsubstituted C 1-12 aliphatic.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 18, 2020
From: BOSTON COLLEGE OFFICE OF TECHNOLOGY TRANSFER AND LICENSING
To: NATIONAL INSTITUTES OF HEALTH, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT
Reel/Frame 052689/0195 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2015
From: HOVEYDA, AMIR H.; SILVERIO, DANIEL L.; PILYUGINA, TATIANA; TORKER, SEBASTIAN; ROBBINS, DANIEL
To: TRUSTEES OF BOSTON COLLEGE
Reel/Frame 034855/0404 →
Continuity (2)
Provisional Application 61605582 · Mar 1, 2012
Related Publication 20150057451A1 · Feb 26, 2015